MA
43
2
CME
46
3
UHS
43
-4
WFC
61
3
IRM
31
3
MPC
63
-5
SLB
42
-2
GPC
56
2
NOV
40
-2
SYY
50
2
PHM
46
3
XYL
58
2
EBAY
49
-10
STI
35
-5
ABBV
66
7
VLO
56
-6
XRX
44
3
PEP
41
-7
MU
48
-4
PSX
57
-7
MA
43
2
CME
46
3
UHS
43
-4
WFC
61
3
IRM
31
3
MPC
63
-5
SLB
42
-2
GPC
56
2
NOV
40
-2
SYY
50
2
PHM
46
3
XYL
58
2
EBAY
49
-10
STI
35
-5
ABBV
66
7
VLO
56
-6
XRX
44
3
PEP
41
-7
MU
48
-4
PSX
57
-7
Financhill
Back

IGC Pharma 10K Form

Sell
33

IGC
IGC Pharma

Last Price:
$0.35
Seasonality Move:
82.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IGC News And Ratings

See the #1 stock for the next 7 days that we like better than IGC

IGC Financial Statistics

Sales & Book Value

Annual Sales: $1.3M
Cash Flow: $-1.4M
Price / Cash Flow: 0
Annual Sales: $0.08
Price / Book: 4.43

Profitability

EPS (TTM): -0.11000
Net Income (TTM): $-8.8M
Gross Margin: $619K
Return on Equity: -116.24%
Return on Assets: -86.02%

IGC Pharma Earnings Forecast

Key IGC Pharma Financial Ratios

  • The Gross Profit Margin over the past 18 years for IGC is 48.70%.
  • The Selling, General & Administrative Expenses for IGC have been equal to 346.97% of Gross Profit Margin.
  • The Research & Development expenses have been 287.57% of Revenue.
  • The Net Earning history of IGC is -560.27% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 10 years.

IGC Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: IGC
CUSIP: 45408X
Website: igcinc.us

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 1.15
Quick Ratio: 0.21

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IGC Technical Analysis vs Fundamental Analysis

Sell
33
IGC Pharma (IGC) is a Sell

Is IGC Pharma a Buy or a Sell?

  • IGC Pharma stock is rated a Sell
    The current IGC Pharma [IGC] share price is $0.33. The Score for IGC is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.